FULL PAPER. Tc-99m MIBI SCINTIGRAPHY IN FOLLOW-UP OF POST-THERAPY DIFFERENTIATED THYROID CARCINOMA (DTC)
|
|
- Coral Miles
- 6 years ago
- Views:
Transcription
1 FULL PAPER Tc-99m MIBI SCINTIGRAPHY IN FOLLOW-UP OF POST-THERAPY DIFFERENTIATED THYROID CARCINOMA (DTC) Yudistiro R, Kartamihardja AHS, and Masjhur JS Department of Nuclear Medicine, School of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia. POSTER PRESENTATION 4 th International Conference on Radiopharmaceutical Therapy New World Hotel, Ho Chi Minh City, Vietnam 28 Nov 2 Dec 2011
2 Tc-99m MIBI SCINTIGRAPHY IN FOLLOW-UP OF POST- THERAPY DIFFERENTIATED THYROID CARCINOMA (DTC) Yudistiro R, Kartamihardja AHS, and Masjhur JS Department of Nuclear Medicine, School of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, Indonesia. Abstract Background. Long terms follow-up should be performed in post-therapy DTC patients by measuring serum thyroglobulin (Tg-off) and Thyroglobulin-antigen antibody (AbTg) level in stimulating TSH level every 6-12 months. NaI-131 scintigraphy is done to detect location of remnant thyroid and/or metastases. 1 NaI-131 scintigraphy has several disadvantages, such as patient s discomforts and stunning effect. 99m Tc-methoxyisobuthyisonitrile (MIBI) is routinely used as tumor seeking agent; the advantages of 99m Tc-MIBI scintigraphy in follow-up of post-therapy DTC patients is still controversy. Diagnostic performance of imaging can be measured by image resolution which is resulted from uptake ratio. Objective. To evaluate the uptake ratio and diagnostic value of 99m Tc-MIBI and NaI-131 scintigraphy using Tg-off level as gold standard. Methods. 99m Tc-MIBI and NaI-131 scintigraphy were done in 56 patients posttotal thyroidectomy and radiothyroablation with NaI-131 who underwent follow up. Maximum counts activity was analyzed from region of interest (ROI) of lesion and background to measure uptake ratio. Background ROI was made in thigh projections.
3 Conclusion. 99m Tc-MIBI scintigraphy is not better than NaI-131 scintigraphy by using Tg-off as gold standard. NaI-131 scintigraphy is still the best methood in follow-up of post-therapy DTC patients. Keywords: Tc-99m MIBI, NaI-131, Thyroglobulin, Differentiated Thyroid Carcinoma Introduction Long terms follow-up should be performed in post-therapy DTC patients by measuring serum thyroglobulin (Tg-off) and Thyroglobulin-antigen antibody (AbTg) level in stimulating TSH level every 6-12 months. The aim of this long terms follw-up is to early detect of remnant malignancy, relapse and far metastases, and monitoring of thyroid stimulating hormone (TSH) suppression. American Thyroid Association 2009 Guidance recommend the use of thyroglobulin-off (Tg-off) serum level as indicator and anti thyroglobulin antibody (Tg-Ab) as validator of Tg-off. 1,2 NaI-131 scintigraphy is done to detect location of remnant normal thyroid and/or metastases with high specificity. 3 NaI-131 scintigraphy has several disadvantages, such as patient s discomforts due to they have to stop thyroid hormone substitution in order to reach TSH stimulation condition at least 10 times of normal limits. In this hypothyroidism condition, patient will suffer due to decrease metabolic activity. Stunning effect is also the other disadvantage of using NaI-131 as diagnostic agent, particularly it is done with high dose and duration between diagnostic test and time of treatment is very close. NaI-131 scintigraphy should be done at 24 and 48 hours post administration of NaI-131, so the procedure is take long time. 4
4 Some studies found discordance between Tg-off serum level result and NaI-131 scintigraphy in post radioiodine ablation patient with DTC. High Tgoff serum level with negative NaI-131 scintigraphy was found in 10-15% of patient with DTC after radioiodine ablation, and on the other hand positive NaI- 131 scintigraphy with low Tg-off serum level were found even less. 4,5 New and non-invasive imaging modalities is a challenge to replace NaI- 131 as diagnostic modality to detect and localize malignancy after radioiodine ablation without stopping TSH substitution and suppression. Radiopharmaceuticals could be used for this imaging modality are 201 Tl, 99m Tctetrofosmin, 99m Tc-MIBI, 111 In-octreotide, 123 I and 18 F-FDG. 4,6,7 99m Tc-methoxyisobuthyisonitrile (MIBI) is a cationic lipophilic. It will be accumulated in mitochondria following intravenous injection. 8 99m Tc-MIBI has been used as a routine tumor seeking agent, since it can be accumulated in malignant cell, such as nasopharynx, lung, parathyroid, breast cancer, multiple myolema and ostegenic sarcoma The advantages of 99m Tc-MIBI scintigraphy in follow-up of post-therapy DTC patients is still controversy. The aim of this study was to evaluate the uptake ratio and diagnostic value of 99m Tc- MIBI and NaI-131 scintigraphy using Tg-off level as gold standard. Material and methods Subjects were patient with DTC who came to Departement of Nuclear Medicine Dr. Hasan Sadikin General Hospital for following up after radioiodine ablation. Subject should be under TSH stimulation with TSH serum level > 30uIU/ml as an obligatory for Tg-off level test and NaI-131 scintigraphy.
5 Measurement of Tg-off serum level and TSH using dual high affinity monoclonal antibody method in immunoradiometric assay (IRMA), and radioimmuno assay is use for Tg-Ab serum level. 99m Tc-MIBI scintigraphy was done 15 minutes and 4 hours after intravenous incjetion of mci ( MBq) of radiopharmaceutical. Total body image was taken by using gamma camera with low energy high resolution, energy setting in 140 KeV, matrix size 256x256, 3.0 zooming and window width 20%. NaI-131 scintigraphy was done after 4-6 weeks without TSH suppression or TSH serum level > 30 miu/ml. NaI-131 image was taken hours after oral administration of 2 mci (74%) NaI-131 by using gamma camera with high energy collimator, energy setting in 364 KeV, matrix size 256x256, 3.0 zooming and window width 20%. Uptake ratio from both images was calculated from radioactivity counts taken from region of interest (ROI) of the target and background. Statistic analysis Statistic analysis was used SPSS program for windows version 13.0 with degree of confidence interval 95% and significance if p value < Bivariate analysis was used to evaluate the different uptake between 99m Tc-MIBI and NaI- 131 by using non-parametric test from Wilcoxon test. Diagnostic test was used to determine sensitivity, specificity, PPV, NPV and accuracy.
6 Results This study was involving 56 subjects consist of 10 (17.9%) male and 46 (82.1%) female, aged range years old (X= ). Histopathological finding was 46 (82.1%) papillary, 9 (16.1) follicular and 1 (1.8%) Hurtle cell. Positive Tg-off serum level was found in 15 (26.8%) and negative 41 (73.2%). Positive Tg-Ab level was found in 25 (44.6%) and negative in 31 (55.4%). Positive 99m Tc-MIBI Scintigraphy was found in 13 (23.2%) and negative in 43 (76.8%). Positive Na-I 131 scintigraphy wa found in 18 (32.1%) and negarive in 38 (67.9). Median and ranged uptake ratio of 99m Tc-MIBI and Na-I 131 were 2.03 ( ) and 1.67 ( ) respectively. Wilcoxon-test with confidence interval 95% showed there was no significance different between 99m Tc-MIBI and Na-I 131 uptake ratio with p value = The results showed 7 (46.7%) out 13 subject with positive 99m Tc-MIBI Scintigraphy were postive Tg-off serum level. and 35 (85.4%) out of 43 subject with negative 99m Tc-MIBI Scintigraphy were negative Tg-off serum level as well. McNemar test with confidence interval 95% showed that there was no significance different between 99m Tc-MIBI Scintigraphy and Tg-off in validation of following up DTC patients after radioiodine ablation with p value = Sensitivity, specificity, PPV, NPV and accuracy of 99m Tc-MIBI Scintigraphy for following up patient with DTC after radioiodine ablation were 46.7%, 85.4%, 53.8%, 81.4% and 75% respectively. The results showed 12 (80%) out 18 subject with positive Na-I 131 scintigraphy were postive Tg-off serum level, and 35 (85.4%) out of 38 subject with negative Na-I 131 scintigraphy were negative Tg-off serum level as well. McNemar test with confidence interval 95% showed that there was no significance different
7 between Na-I 131 scintigraphy and Tg-off in validation of following up DTC patients after radioiodine ablation with p value = Sensitivity, specificity, PPV, NPV and accuracy of Na-I 131 scintigraphy for following up patient with DTC after radioiodine ablation were 80.0%, 85.4%, 66.7%, 92.1% and 83.9% respectively. (table 1) Tabel 1. Diagnostic value of 99m Tc-MIBI Scintigraphy and Na-I 131 scintigraphy. Variable Thyroglobulin Diagnostic Value Positive Negative Sensitivity Specificity PPV NPV Accuracy 99m Tc-MIBI Scintigraphy 46.7 % 85.4 % 53.8 % 81.4 % 75 % Positive 7 6 Negative 8 35 NaI-131 Scintigraphy 80.0 % 85.4 % 66.7 % 92.1 % 83.9 % Positive 12 6 Negative 3 35 A B FIGURE 1. Tc-99m MIBI scintigraphy in 53 years old male with positive Tg-off and negative AbTg showed pathological uptake (arrow) in thyroid bed (A), while in NaI-131 there is no pathological uptake in thyroid bed (B)
8 A B FIGURE 2. Tc-99m MIBI scintigraphy in 33 years old female with negative Tg-off and positive AbTg showed pathological uptake (arrow) in thyroid bed (A), while in NaI-131 there is no pathological uptake in thyroid bed (B) False positive may be due to inflammation or muscle activity. Discussion 99m Tc-MIBI has been using as tumor seeking agent in many studies. This radiopharmaceutical can be use to detect malignancy in solitary thyroid nodule. 15 This study showed there is no significance different uptake ratio between 99m Tc-MIBI Scintigraphy and NaI-131 scintigraphy, but median uptake of 99m Tc-MIBI Scintigraphy was higher compared to NaI-131 scintigraphy. This differences could be due to difference gamma ray energy level of 99m Tc-MIBI more ideal for gamma camera detector compared to NaI-131. Sensitivity and specificity of both modalities were similar to other studies. The sensitivity and specificity of 99m Tc-MIBI Scintigraphy were % and 89-94% respectively, while NaI-131 scintigraphy were 47-84% and 96-99% respectively. 10 Low sensitivity of 99m Tc-MIBI Scintigraphy could be due to high backgroud uptake of 99m Tc-MIBI. ROI of background was taken from soft tissue (sceletal muscle) which is consist a lot of mitochondria, while NaI-131 is
9 not taken up by sceletal muscle. The other reason of low sensitivity of 99m Tc- MIBI Scintigraphy due to metabolic and blood flow degradation, and cell membrane disorder of thyroid cell after radioiodine ablation. On the othe hand the sensitivity of NaI-131 scintigraphy was higher due to this radiopharmaceutical will be taken by both normal thyroid tissue and thyroid cancer. 10 This study showed 8 subjects with positive Tg-off serum level, but negative on 99m Tc-MIBI Scintigraphy considered as false negative. False negative result of 99m Tc-MIBI Scintigraphy could be due to the size of cancer too small (microcarcinoma) to be detected with gamma camera with spatial resulution >0.5 cm. 16 False positive result of 99m Tc-MIBI Scintigraphy was observed in 6 subjects could be due to high uptake in sceletal muscle. It is recommended not to do physical exercise to whom 99m Tc-MIBI Scintigraphy procedure will be applied. False negative result in NaI-131 scintigraphy could be due to uptake mechanism disorder, dedifferentiated tumor cell, and microcarcinoma. False positive results of NaI-131 scintigraphy could be due to normal uptake of choroidal flexus, salivary gland, gastric mucous, and urinary tract. 4 In this study 25 subject with postive Tg-Ab showed 16 subjects with negative Tg-off and 9 positive. Four out of 16 subjects showed positive 99m Tc- MIBI Scintigraphy and 1 subject showed positive NaI-131 scintigraphy. In 8 out of 9 subject showed positive NaI-131 scintigraphy. Positive 99m Tc-MIBI Scintigraphy was observed in all subject with positive Tg-off and positive Tg- Ab. This results showed that 99m Tc-MIBI Scintigraphy has capability to detect more remnant thyroid cancer in all subject with postive Tg-Ab.
10 The advantage of 99m Tc-MIBI Scintigraphy was the procedure could be done in TSH suppresion and no stunning effect. The patient could continue to take thyroid hormone substitution. Conclusion The conclusion of this study were 99m Tc-MIBI scintigraphy was not better procedure than NaI-131 scintigraphy as following up patients with DTC after radioiodine ablation by using Tg-off as gold standard. NaI-131 scintigraphy is still the method of choice in follow-up patients with DTC after radioiodine ablation. References 1. Schlumberger M, Pacini F. Follow-up: Lessons from the pass. In Papillary and follicular thyroid carcinoma. Paris: Nuclean 2006;h: ATA (American Thyroid Association) Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009;19: Caron NR, Clark OH. Well differentiated thyroid carcinoma. Scandinavian Journal of Surgery 2004;93: Ma C, Kuang A, Xie J, and Ma T. Possible explanations for patients with discordant findings of serum thyroglobulin and 131 I Whole body scanning. J Nucl Med 2005;46: Masjhur JS and Kartamihardja. Buku Pedoman Tatalaksana Diagnostik dan Terapi Kedokteran Nuklir. RS Hasan Sadikin/Fakultas Kedokteran Universitas Padjadjaran
11 6. Ronga G, Fiorentino A, Paserio E, Signore A, Todino V, Tumarello MA et al. Can I-131 whole body scan be replaced by thyroglobulin measurementin the post-surgical follow up of differentiated thyroid carcinoma? J Nucl Med 1990;31: Kloos RT. Approach to the patient with positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer. J Clin Endocrinol Metab. 2008;93(5): Arbab AS, Kizumi K, Toyama K and Araki T. Uptake of Technetium-99m Tetrofosmin, Technetium-99m MIBI and Thallium-201 in tumor cell lines. J Nucl Med 1996;37: Hidayat B, AHS. Kartamihardja, dan Masjhur JS. Deteksi keganasan payudarah menggunakan Technetium-99m Sestamibi. MKB. 2002; 34(1) 10. Fujie et al. Diagnostic Capabilities of I-131, Tl-201 and Tc-99m MIBI Scintigraphy for Metastatic Differentiated Thyroid Carcinoma after Total Thyroidectomy. Acta Med. Okayama 2005;59(3): Kucuk NO, Kulak HA and Aras G. Clinical importance of technetium-99m methoxyisobuthylisonitrile (MIBI) scintigraphy in differentiated thyroid carcinoma patients with elevated thyroglobulin levels and negative I-131 scanning results. Annals of Nuclear Medicine, 2006;20(6): Eng Ng DC, Sundram FX and Sin AE. 99m Tc-sestamibi and 131 I whole body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma. J Nucl Med 2000;41: Miyamoto S, Kasagi K, Misaki T, Alam MS and Konisi J. Evaluation of technetium-99m MIBI scintigraphy in metastatic differentiated thyroid carcinoma. J Nucl Med 1997;38:
12 14. Al Saleh, Safwat R, Al-Shammeri I, Naseer MA, Hooda H and Al- Mohannadi S. Comparison of Whole Body Scintigraphy with Tc-99m methoxyisobuthylisonitrile and Iodine-131Na in Patients with Differentiated Thyroid Cancer. G.J.O 2007;1(1): Fukumoto M. Single-photon agents for tumor imaging: Tl-201, Tc-99m MIBI, and Tc-99m Tetrofosmin. Annal of Nucl Med 2004;18: Bizhanova A and Kopp P. minireview: The Sodium-Iodide Sympoter NIS and Pendrin in Iodide Homeostasis of the thyroid. Endocrinology 2009;150:
13
14
15
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer
Case 4: Disseminated bone metastases from differentiated follicular thyroid cancer Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Disseminated bone
More informationMINERVA MEDICA COPYRIGHT
Q J NUCL MED MOL IMAGING 2007;51:364-71 Sensitivity of [ 99m Tc]methoxyisobutylisonitrile scan in patients with metastatic differentiated thyroid cancer Aim. The aim of the present study was to evaluate
More informationInternational Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer
Nuclear Medicine Review 2006 Vol. 9, No. 1, pp. 84 88 Copyright 2006 Via Medica ISSN 1506 9680 International Czech and Slovak cooperation in the treatment of patients with differentiated thyroid cancer
More informationImaging in Pediatric Thyroid disorders: US and Radionuclide imaging. Deepa R Biyyam, MD Attending Pediatric Radiologist
Imaging in Pediatric Thyroid disorders: US and Radionuclide imaging Deepa R Biyyam, MD Attending Pediatric Radiologist Imaging in Pediatric Thyroid disorders: Imaging modalities Outline ACR-SNM-SPR guidelines
More informationThyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma.
ORIGINAL ARTICLE Thyroid remnant volume and Radioiodine ablation in Differentiated thyroid carcinoma. Md. Sayedur Rahman Miah, Md. Reajul Islam, Tanjim Siddika Institute of Nuclear Medicine & Allied Sciences,
More information2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines
2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results
More informationFULL PAPER THERAPEUTIC RESPONSE EVALUATION ON HYPERTHYROIDISM USING A FIXED DOSED OF I-131
FULL PAPER THERAPEUTIC RESPONSE EVALUATION ON HYPERTHYROIDISM USING A FIXED DOSED OF I-131 Yulia Kurniawati, and AHS Kartamihardja Department of Nuclear Medicine, Dr. Hasan Sadikin General Hospital, Faculty
More informationCase 5: Thyroid cancer in 42 yr-old woman with Graves disease
Case 5: Thyroid cancer in 42 yr-old woman with Graves disease Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Thyroid cancer in 42 yr-old woman with
More informationAustin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide)
Austin Radiological Association Nuclear Medicine Procedure THERAPY FOR THYROID CANCER (I-131 as Sodium Iodide) Overview Indications I-131 therapy for Thyroid Cancer, of the papillo-follicular type, is
More informationNuclear Medicine Head and Neck Region. Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine
Nuclear Medicine Head and Neck Region Bán Zsuzsanna, MD University of Pécs, Department of Nuclear Medicine Thyroid scintigraphy Parathyroid scintigraphy F18-FDG PET examinations in head and neck cancer
More informationAN INTRODUCTION TO NUCLEAR MEDICINE
AN INTRODUCTION TO NUCLEAR MEDICINE WITH RESPECT TO THYROID DISORDERS By: B.Shafiei MD Nuclear Physician Taleghani Medical Center Radioactive: An element with Unstable Nucleus (Excess Energy), can achieve
More informationTime of maximum uptake of Technetium-99m pertechnetate (TcO4) in the thyroid gland and its correlation with thyroid functional status
Time of maximum uptake of Technetium-99m pertechnetate (TcO4) in the thyroid gland and its correlation with thyroid functional status Md. Mizanur Rahman 1*, Dr. Shankar Kumar Dey 2 1 Center For Research
More informationStrategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer
Strategies for detection of recurrent disease in longterm follow-up of differentiated thyroid cancer A rational approach to longterm follow-up based on dynamic risk assessment. World Congress on Thyroid
More informationDiagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer
European Journal of Endocrinology (2004) 150 649 653 ISSN 0804-4643 CLINICAL STUDY Diagnostic 131 I whole body scanning after thyroidectomy and ablation for differentiated thyroid cancer Henry Taylor,
More informationRole of Radio-Iodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer
Journal of the Egyptian Nat. Cancer Inst., Vol. 13, No. 1, March: 6369, 2001 Role of RadioIodine Ablation According to Risk Stratification in Well Differentiated Thyroid Cancer HOSNA MOUSTAFA, M.D.*; SHEREEN
More informationRESEARCH ARTICLE. Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer
RESEARCH ARTICLE Importance of Postoperative Stimulated Thyroglobulin Level at the Time of 131 I Ablation Therapy for Differentiated Thyroid Cancer Zekiye Hasbek 1 *, Bulent Turgut 1, Fatih Kilicli 2,
More informationThis was a multinational, multicenter study conducted at 14 sites in both the United States (US) and Europe (EU).
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription. NAME OF SPONSOR/COMPANY: Genzyme Corporation,
More informationAlthough adequate treatment of differentiated thyroid
Serum Thyroglobulin Concentrations and 131 I Whole-Body Scan Results in Patients with Differentiated Thyroid Carcinoma After Administration of Recombinant Human Thyroid-Stimulating Hormone Alessia David,
More information131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans
131-I Therapy Planning in Thyroid Cancer: The role of diagnostic radioiodine scans Anca M. Avram, M.D. Associate Professor of Radiology Department of Nuclear Medicine University of Michigan Ann Arbor,
More information저작권법에따른이용자의권리는위의내용에의하여영향을받지않습니다.
저작자표시 - 비영리 - 변경금지 2.0 대한민국 이용자는아래의조건을따르는경우에한하여자유롭게 이저작물을복제, 배포, 전송, 전시, 공연및방송할수있습니다. 다음과같은조건을따라야합니다 : 저작자표시. 귀하는원저작자를표시하여야합니다. 비영리. 귀하는이저작물을영리목적으로이용할수없습니다. 변경금지. 귀하는이저작물을개작, 변형또는가공할수없습니다. 귀하는, 이저작물의재이용이나배포의경우,
More informationNuclear medicine in endocrinology
Nuclear medicine in endocrinology Thyroid gland: anatomy, function, inflammation, Nuclear medicine in endocrinology tumor dignitiy Parathyroid gland: localisation Adrenal cortex: function Adrenal medulla:
More informationRadioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body I-131 Imaging: A Case Series
Int J Endocrinol Metab. 2014 January; 12(1): e9329. Published online 2014 January 1. DOI: 10.5812/jjm.9329 Case Report Radioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body
More information42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%
Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake
More informationSuccess rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan
ORIGINAL ARTICLE Success rate of thyroid remnant ablation for differentiated thyroid cancer based on 5550 MBq post-therapy scan I. Hommel 1 *, G.F. Pieters 1, A.J.M. Rijnders 2, M.M. van Borren 3, H. de
More informationTHYROID IMAGING STUDY (Tc-99m as Sodium Pertechnetate)
THYROID IMAGING STUDY (Tc-99m as Sodium Pertechnetate) Overview Indications The Thyroid Imaging Study with Tc-99m-pertechnetate demonstrates the distribution of tissues that take up anions. Such tissues
More informationIndex. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACC. See Adrenal cortical carcinoma. Acromegaly and the pituitary gland, 551 Acute suppurative thyroiditis, 405, 406 Addison, Thomas and
More informationCorrespondence should be addressed to Stan H. M. Van Uum;
Oncology Volume 2016, Article ID 6496750, 6 pages http://dx.doi.org/10.1155/2016/6496750 Research Article Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive
More information3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women
Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica
More informationIndex. Surg Oncol Clin N Am 15 (2006) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 15 (2006) 681 685 Index Note: Page numbers of article titles are in boldface type. A Ablative therapy, for liver metastases in patients with neuroendocrine tumors, 517 with radioiodine
More information1. OVERVIEW AND INDICATIONS
1. OVERVIEW AND INDICATIONS (adapted from Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy and other sources) a) Evaluation of the general structure of the thyroid gland (e.g. nodular
More informationRESEARCH ARTICLE. Comparison of Presentation and Clinical Outcome between Children and Young Adults with Differentiated Thyroid Cancer
RESEARCH ARTICLE Comparison of Presentation and Clinical Outcome between Children and Young Adults with Jian-Tao Wang 1,2&, Rui Huang 1&, An-Ren Kuang 1 * Abstract Background: The aim of the present study
More informationImaging Journal of Clinical and Medical Sciences ISSN: DOI CC By
Clinical Group Imaging Journal of Clinical and Medical Sciences ISSN: 2455-8702 DOI CC By Daniella F Pinho* Department of Radiology, University of Texas Southwestern Medical Center, Texas, USA Dates: Received:
More informationEndocrine, Original Article The Impact of Thyroid Stunning on Radioactive Iodine Ablation Compared to Other Risk Factors
68 Endocrine, Original Article The Impact of Thyroid Stunning on Radioactive Iodine Ablation Compared to Other Risk Factors Abd El-Kareem, M *, El-Refaie, SH *, Zaher, A **, Abo-Gaba, Ml * and Abdo, S
More informationThyroid carcinoma. Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec.
Thyroid carcinoma Assoc. prof. V. Marković, MD, PhD Assoc. prof. A. Punda, MD, PhD D. Brdar, MD, nucl. med. spec. Thyroid tumors PRIMARY TUMORS Tumors of the follicular epithelium : - Tumors of the follicular
More informationThyroid Cancer: Imaging Techniques (Nuclear Medicine)
Thyroid Cancer: Imaging Techniques (Nuclear Medicine) Andrei Iagaru, MD MIPS Molecular Imaging Program at Stanford Stanford University School of Medicine Department of Radiology Introduction Ø There are
More informationPET/CT in thyroid carcinoma
Arch Oncol 2012;20(3-4):112-6. UDC: 616-006.441:616-073.4 DOI: 10.2298/AOO1204112M Department of Nuclear Medicine, Oncology Institute of Vojvodina, Sremska Kamenica, Serbia Correspondence to: Jasna Mihailović,
More informationAdjuvant therapy for thyroid cancer
Carcinoma of the thyroid Adjuvant therapy for thyroid cancer John Hay Department of Radiation Oncology Vancouver Cancer Centre Department of Surgery UBC 1% of all new malignancies 0.5% in men 1.5% in women
More informationOTHER NON-CARDIAC USES OF Tc-99m CARDIAC AGENTS Tc-99m Sestamibi for parathyroid imaging, breast tumor imaging, and imaging of other malignant tumors.
DEFINITION OF CARDIAC RADIOPHARMACEUTICAL: A radioactive drug which, when administered for purpose of diagnosis of heart disease, typically elicits no physiological response from the patient. Even though
More informationPersistent & Recurrent Differentiated Thyroid Cancer
Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of
More informationAnca M. Avram, M.D. Professor of Radiology
Thyroid Cancer Theranostics: the case for pre-treatment diagnostic staging 131-I scans for 131-I therapy planning Anca M. Avram, M.D. Professor of Radiology Department of Nuclear Medicine University of
More informationThyroid Cancer. With 51 Figures and 30 Tables. Springer
H.-J. Biersack F. Griinwald (Eds.) Thyroid Cancer With 51 Figures and 30 Tables Springer PART 1 Basics 1 The Changing Epidemiology of Thyroid Cancer 3 R. GORGES 1.1 Basic Epidemiological Problems in Thyroid
More informationI-123 Thyroid Scintigraphy
APPROVED BY: Director of Radiology Page 1 of 6 I-123 Thyroid Scintigraphy Primary Indications: Thyroid scintigraphy with I-123 is indicated to evaluate thyroid morphology and global and/or regional function
More information2. RADIOPHARMACEUTICALS UTILIZED
1. OVERVIEW AND INDICATIONS (adapted from Society of Nuclear Medicine Procedure Guideline for Thyroid Uptake Measurement, Version 3.0; reprinted from http://snmmi.files.cmsplus.com/docs/thyroid%20uptake%20measure%20v3%200.pdf,
More informationI-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Advances in Medical and Surgical Management of Thyroid Cancer January 23-24, 2015 I-131 ABLATION AND ADJUVANT THERAPY OF THYROID CANCER 2015 Leonard Wartofsky,
More informationTHYROID CANCER IN CHILDREN
THYROID CANCER IN CHILDREN Isabel ROCA, Montserrat NEGRE Joan CASTELL HU VALL HEBRON BARCELONA EPIDEMIOLOGY ADULTS males 1,2-2,6 cases /100.000 females 2,0-3,8 cases /100.000 0,02-0,3 / 100.000 children
More informationThe correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy 99m Tc-DTPA study
Journal of Physics: Conference Series PAPER OPEN ACCESS The correlation between effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) with renal scintigraphy Tc-DTPA study To cite this
More informationTOTAL OR NEAR-TOTAL thyroidectomy is advocated in
0013-7227/03/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 88(3):1107 1111 Printed in U.S.A. Copyright 2003 by The Endocrine Society doi: 10.1210/jc.2002-021365 Positive Predictive Value
More informationTHE AIM OF postsurgical follow-up in patients with differentiated
0013-7227/01/$03.00/0 The Journal of Clinical Endocrinology & Metabolism 86(12):5686 5690 Printed in U.S.A. Copyright 2001 by The Endocrine Society Prediction of Disease Status by Recombinant Human TSH-Stimulated
More informationParathyroid Imaging What is best
Parathyroid Imaging What is best Mike Avison Bradford Why me? I m honoured to be asked to present this. There is no killer paper or text which clearly proves the best methodology. Bradford has performed
More informationRisk Adapted Follow-Up
Risk Adapted Follow-Up Individualizing Follow- Up Strategies R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College
More informationRESEARCH ARTICLE. Abstract. Introduction
RESEARCH ARTICLE Baseline Stimulated Thyroglobulin Level as a Good Predictor of Successful Ablation after Adjuvant Radioiodine Treatment for Differentiated Thyroid Cancers Nosheen Fatima 1, Maseeh uz Zaman
More informationRadionuclide Therapy. Prof. Dr. Çetin Önsel. Cerrahpaşa Medical School Department of Nuclear Medicine. Radionuclide Therapy
Prof. Dr. Çetin Önsel Cerrahpaşa Medical School Department of Nuclear Medicine Principles of radionuclide therapy (1) The radionuclide has to be concentrated at the site of the abnormality (tumor) with
More informationS C Ong, D C E Ng, F X Sundram ABSTRACT
O r i g i n a l A r t i c l e Singapore Med J 2005; 46(6) : 297 Initial experience in use of fluorine-18- fluorodeoxyglucose positron emission tomography/ computed tomography in thyroid carcinoma patients
More informationDifferentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment
ORIGINAL ARTICLE Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment Martínez MP, Lozano Bullrich MP, Rey M, Ridruejo MC, Bomarito MJ, Claus
More informationGerard M. Doherty, MD
Surgical Management of Differentiated Thyroid Cancer: Update on 2015 ATA Guidelines Gerard M. Doherty, MD Chair of Surgery Utley Professor of Surgery and Medicine Boston University Surgeon-in-Chief Boston
More informationPediatric Thyroid Cancer Lung Metastases. Liora Lazar MD
Pediatric Thyroid Cancer Lung Metastases Liora Lazar MD Differentiated thyroid cancer (DTC) The 3rd most common solid tumor in childhood and adolescence Accounting for 1.5%-3% of all childhood cancers
More informationPrimary hyperparathyroidism (HPT) has an incidence of
Dual-Phase Tc-Sestamibi Imaging: Its Utility in Parathyroid Hyperplasia and Use of Immediate/ Delayed Image Ratios to Improve Diagnosis of Hyperparathyroidism Leonie Gordon, MD; William Burkhalter, MD;
More informationNuclear Medicine: Manuals. Nuclear Medicine. Nuclear imaging. Emission imaging: study types. Bone scintigraphy - technique
Nuclear Medicine - Unsealed radioactive preparations the tracer mixes with the patients body fluids on a molecular level (e.g. after intravenous injection) - 3 main fields: - In vitro : measuring concentrations
More informationAustin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide)
Austin Radiological Association Nuclear Medicine Procedure THYROID UPTAKE MEASUREMENT (I-123 or I-131 as Sodium Iodide) Overview Indications The Thyroid Uptake Measurement measures the metabolic activity
More informationThyroid Cancer & rhtsh: When and How?
Thyroid Cancer & rhtsh: When and How? 8 th Postgraduate Course in Endocrine Surgery Capsis Beach, Crete, September 21, 2006 Quan-Yang Duh, Professor of Surgery, UCSF Increasing Incidence of Thyroid Cancer
More informationLow - dose radioiodine ablation of remnant thyroid in high - risk differentiated thyroid carcinoma
K. SUZUKI, et al : radioiodine ablation in DTC 141 J. Tokyo Med. Univ., 72 2 : 141-147, 2014 Low - dose radioiodine ablation of remnant thyroid in high - risk differentiated thyroid carcinoma Kunihito
More informationAbout OMICS International
About OMICS International OMICS International through its Open Access Initiative is committed to make genuine and reliable contributions to the scientific community. OMICS International hosts over 700
More informationEANM Procedure Guideline For Therapy with Iodine-131
EANM Procedure Guideline For Therapy with Iodine-131 I. PURPOSE The purpose of this guideline is to assist nuclear medicine practitioners in 1. evaluating patients who might be candidates for therapy with
More informationPEDIATRIC Ariel Katz MD
PEDIATRIC Ariel Katz MD Dept. Otolaryngology Head &Neck Surgery Wolfson Medical Center Holon, Israel OBJECTIVES Overview/Background Epidemiology/Etiology Intro to Guidelines Workup Treatment Follow-Up
More informationDifferentiated Thyroid Cancer: Initial Management
Page 1 ATA HOME GIVE ONLINE ABOUT THE ATA JOIN THE ATA MEMBER SIGN-IN INFORMATION FOR PATIENTS FIND A THYROID SPECIALIST Home Management Guidelines for Patients with Thyroid Nodules and Differentiated
More informationCase Report Unexpected Bone Metastases from Thyroid Cancer
Case Reports in Endocrinology Volume 2015, Article ID 434732, 4 pages http://dx.doi.org/10.1155/2015/434732 Case Report Unexpected Bone Metastases from Thyroid Cancer Sandra Gibiezaite, 1 Savas Ozdemir,
More informationCLINICAL CONSIDERATIONS FOR I-131 THERAPY
CLINICAL CONSIDERATIONS FOR I-131 THERAPY Oneil Lee, MD, PhD Kaiser Permanente Orange County Department of Radiology/Nuclear Medicine GOAL Understand thyroid cancer: Biology, epidemiology, treatment strategies,
More informationAccuracy of Unstimulated Basal Serum Thyroglobulin Levels in Assessing the Completeness of Thyroidectomy
Elmer Original Article ress Accuracy of Unstimulated Basal Serum Thyroglobulin Levels in Assessing the Completeness of Thyroidectomy Emin Gurleyik a, b, Sami Dogan a Abstract Background: Complete excision
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationEvaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
More informationEMPIRIC 131 I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION
Acta Medica Mediterranea, 2014, 30: 503 EMPIRIC 131 I TREATMENT OF HIGH THYROGLOBULIN LEVELS IN DIFFERENTIATED THYROID CARCINOMA AFTER REMNANT ABLATION EBUZER KALENDER*, UMUT ELBOGA*, Y. ZEKI ÇELEN*, H.
More informationradioactive iodine (iodine-131) Knowing the benefits and risks of radioactive iodine enables you and your doctor to decide WHAT S RIGHT FOR YOU.
to consider if you should receive radioactive Knowing the benefits and risks of radioactive iodine enables you and your doctor to decide WHAT S RIGHT FOR YOU. It is in your best interest to have an active
More informationDisclosures. Learning objectives. Case 1A. Autoimmune Thyroid Disease: Medical and Surgical Issues. I have nothing to disclose.
Disclosures Autoimmune Thyroid Disease: Medical and Surgical Issues I have nothing to disclose. Chrysoula Dosiou, MD, MS Clinical Assistant Professor Division of Endocrinology Stanford University School
More informationa Department of Radiological Sciences, Unit of Nuclear Medicine and b Clinical
Original article Clinical usefulness of 99m Tc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer Alfredo Campennì a, Maria A. Violi b, Rosaria M. Ruggeri b,
More informationDr J K Jekel Dept. Surgery University of Pretoria
Dr J K Jekel Dept. Surgery University of Pretoria No Maybe ( T`s and C`s apply ) 1. Total thyroidectomy 2. Neck dissection only if nodes are involved 3. Ablative dose or doses of Radioactive Iodine 4.
More informationA case of metastatic follicular thyroid carcinoma complicated with Graves disease after total thyroidectomy
2017, 64 (12), 1143-1147 Original A case of metastatic follicular thyroid carcinoma complicated with Graves disease after total thyroidectomy Mariko Aoyama 1), Hiromitsu Takizawa 1), Mitsuhiro Tsuboi 1),
More information1. Protocol Summary Summary of Trial Design. IoN
1. Protocol Summary 1.1. Summary of Trial Design Title: Short Title/acronym: IoN Is ablative radioiodine Necessary for low risk differentiated thyroid cancer patients IoN EUDRACT no: 2011-000144-21 Sponsor
More informationA rare case of solitary toxic nodule in a 3yr old female child a case report
Volume 3 Issue 1 2013 ISSN: 2250-0359 A rare case of solitary toxic nodule in a 3yr old female child a case report *Chandrasekaran Maharajan * Poongkodi Karunakaran *Madras Medical College ABSTRACT A three
More informationMandana Moosavi 1 and Stuart Kreisman Background
Case Reports in Endocrinology Volume 2016, Article ID 6471081, 4 pages http://dx.doi.org/10.1155/2016/6471081 Case Report A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in
More informationDifferentiated thyroid cancer (DTC) occurs in 3 5 per
Integrated PET/CT in Differentiated Thyroid Cancer: Diagnostic Accuracy and Impact on Patient Management Holger Palmedo, MD 1 ; Jan Bucerius, MD 1 ; Alexius Joe, MD 1 ; Holger Strunk, MD 2 ; Niclas Hortling,
More informationTHE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE
THE PARATHYROID GLAND THEORY AND NUCLEAR MEDICINE PRACTICE George N. Sfakianakis MD Professor of Radiology and Pediatrics Director, Division of Nuclear Medicine UM/JMMC Miami FL October 2009 ENDONCRINE
More informationRESEARCH ABSTRACT. What this study adds: Dr George Mukhari Academic Hospital, Sefako Makgatho Health Sciences University, Ga-Rankuwa, South Africa
The impact of the extent of thyroid resection complemented by radioiodine management on disease free status and discharge rates among differentiated thyroid cancer patients: A retrospective analysis Mpumelelo
More informationFundamentals of Nuclear Cardiology. Terrence Ruddy, MD, FRCPC, FACC
Fundamentals of Nuclear Cardiology Terrence Ruddy, MD, FRCPC, FACC Objectives To understand the Principles of Nuclear Cardiac Imaging Radiotracers Image acquisition and processing Stress protocols To appreciate
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationReview Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update
Bangladesh J Otorhinolaryngol 2010; 16(2): 126-130 Review Article Management of papillary and follicular (differentiated) thyroid carcinoma-an update Md. Abdul Mobin Choudhury 1, Md. Abdul Alim Shaikh
More informationNuclear Medicine in Thyroid Cancer. Phillip J. Koo, MD Division Chief of Diagnostic Imaging
Nuclear Medicine in Thyroid Cancer Phillip J. Koo, MD Division Chief of Diagnostic Imaging Financial Disclosures Bayer Janssen Learning Objectives To learn the advantages and disadvantages of SPECT/CT
More informationEgyptian J. Nucl. Med., Vol. 11, No. 1, Dec
Egyptian J. Nucl. Med., Vol. 11, No. 1, Dec 2015 62 Original Paper, Endocrine I-131 Avid Versus FDG avid Loco-Regional Recurrent Differentiated Thyroid Carcinoma;Clinic-Pathological, Diagnostic & Therapy
More informationFollow-up of patients with thyroglobulinantibodies: Rising Tg-Ab trend is a risk factor for recurrence of differentiated thyroid cancer
Endocrine Research ISSN: 0743-5800 (Print) 1532-4206 (Online) Journal homepage: http://www.tandfonline.com/loi/ierc20 Follow-up of patients with thyroglobulinantibodies: Rising Tg-Ab trend is a risk factor
More informationDifferential expression of the Na + /I symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues
368 Differential expression of the Na + /I symporter protein in thyroid cancer and adjacent normal and nodular goiter tissues SHASHA WANG 1, JUN LIANG 1, YANSONG LIN 2 and RUYONG YAO 3 1 Department of
More informationControversies Regarding the Management of Carcinoma of the Thyroid Gland
TAJ June 2003; Volume 16 Number 1 ISSN 1019-8555 The Journal of Teachers Association RMC, Rajshahi Controversies Regarding the Management of Carcinoma of the Thyroid Gland T Begum 1, A B Siddique 1, M
More informationRadiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey
Radiopharmaceutical Activities Administered for Diagnostic and Therapeutic Procedures in Nuclear Medicine in Argentine: Results of a National Survey A. M. Bomben, C. A. Chiliutti Autoridad Regulatoria
More informationRecent initiatives of the FANC. Michel Biernaux Health Protection Service Health and Environment Department
Recent initiatives of the FANC Michel Biernaux Michel.biernaux@fanc.fgov.be Health Protection Service Health and Environment Department Reminder objectives of the national survey : 1.Review the average
More informationSodium Iodide I 131 Solution. Click Here to Continue. Click Here to Return to Table of Contents
Sodium Iodide I 131 Solution Package inserts are current as of January, 1997. Contact Professional Services, 1-888-744-1414, regarding possible revisions Click Here to Continue Click Here to Return to
More informationInternational Journal of Innovative Research in Advanced Engineering (IJIRAE) ISSN:
DETERMINATION OF TC-99m ACTIVITY AND THYROID UPTAKE IN MEN AND WOMEN PATIENTS USING GAMMA CAMERA Oktarina Damayanti *, Wahyu Setiabudi **, Eko Hidayanto *** Magister of Physics, Faculty of Science and
More informationNuclear Medicine Diagnosis
Anatomy : MRI Fonction : Nucl Med Nuclear Medicine Diagnosis Functional imaging = distribution of a (radio)- tracer in organs Each tracer is a SPY of a function, usually through a metabolic pathway flow
More informationDilemma in diagnosing thyroid adenoma A case report
BRIEF REPORT Dilemma in diagnosing thyroid adenoma A case report Faria Nasreen, Shamsun Nahar Bailey National Institute of Nuclear Medicine & Allied Sciences, BAEC, Dhaka, Bangladesh Correspondence: Faria
More information4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.
Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:
More informationIndex. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.
Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic
More informationResearch Article Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas and Larger Tumors
Hindawi International Endocrinology Volume 2017, Article ID 4208178, 8 pages https://doi.org/10.1155/2017/4208178 Research Article Therapeutic Outcomes of Patients with Multifocal Papillary Thyroid Microcarcinomas
More informationThyroglobulin Interference in the Determination of Thyroglobulin Antibody in Wash-Out Fluid from Fine Needle Aspiration Biopsy of Lymph Node
ORIGINAL ARTICLE Thyroglobulin Interference in the Determination of Thyroglobulin Antibody in Wash-Out Fluid from Fine Needle Aspiration Biopsy of Lymph Node Ibáñez N 1, Cavallo A.C 2, Smithuis F 1, Negueruela
More information